bipolar disorder

8560840624_7452a42f5e_k

Introduction

Bipolar, otherwise known as manic depression, now exists largely within common consciousness and understanding, thanks to high profile stigma-busting publicity.

Characterised by episodic shifts in a person’s mood (between manic and depressed states), as well as their energy and activity levels, which can significantly impact their daily functioning, bipolar is estimated to affect 1% of the population across the lifetime. However, this figure rises to over 4% if you include those who experience more than one episode of sub-threshold manic (or ‘hypomanic’) symptoms.

What we know already

Anxiety is unsurprisingly common in people living with bipolar. Similarly, substance abuse is frequently reported.

Whilst there is no cure, there are several well-established treatment options. Bipolar is usually treated using mood-stabiliser, atypical anti-psychotic and/or antidepressant medications, alongside psychological, and diet and lifestyle interventions. We know, for example, that bipolar can be well managed using regular monitoring of mood, keeping stress levels to a minimum, and ensuring good sleep.

Areas of uncertainty 

Like many mental health difficulties, the precise causes of bipolar are unknown, though they are likely multi-faceted. Research shows that you are more likely to develop bipolar if it exists in your family. Although most children with such circumstances will not go on to develop bipolar, there appears to be a strong genetic component. Environmental factors such as stressful life events are also thought to play an important role.

Recent research suggests that, whilst it appears beneficial to treat bipolar with psychological interventions, the heterogeneity of the evidence makes it difficult to decide which treatments (such as CBT, Mindfulness etc) work best.

What’s in the pipeline?

Large-scale studies, such as the U.S-based Bipolar Disorder Phenome Database, are seeking to better understand the complex genetic picture.

Advances in brain imaging will no doubt provide rich information regarding the neurochemical and neurostructural profile of bipolar. Similarly, technological advances are enabling more sophisticated ways of promoting self-management in conditions such as bipolar.

References

Merikangas, K.R., Akiskal, H.S., Angst, J., et al. (2007) Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. Archives of General Psychiatry, 64, 543-552. [Abstract]

Stratford, H.J., Cooper, M.J., Di Simplicio, M., Blackwell, S.E. and Holmes, E.A. (2015) Psychological therapy for anxiety in bipolar spectrum disorders: a systematic review. Clinical Psychology Review, 35, 19-34. [Abstract]

Acknowledgement

Written by: Patrick Kennedy-Williams
Reviewed by:
Last updated: Sep 2015
Review due: Sep 2016

Our bipolar disorder Blogs

No sexual health history please, we’re British!

67865829_18e7655583_b

Kirsten Lawson presents the results of a systematic review of observational cross-sectional studies, which looks at the worldwide prevalence of HIV, hepatitis B and hepatitis C in people with severe mental illness.

[read the full story...]

Does QOF reduce hospitalisation for people with severe mental illness?

6324322996_fe28cf8218_b

Andres Fonseca appraises a regression analysis looking at the quality and outcomes framework (QOF) and the impact it has on psychiatric admissions in people with severe mental illness.

[read the full story...]

Improving diagnosis of bipolar disorder: can blood-based diagnostic panels help?

4279057066_8bd5ec1411_b

Can blood-based diagnostic panels help us reduce the misdiagnosis and inappropriate treatment often experienced by people with bipolar disorder? Murtada Alsaif reviews a recent retrospective study that has some encouraging findings for biologically identifying the disease.

[read the full story...]

Employment opportunities for all? Social enterprises and mental health

Screen Shot 2015-11-04 at 10.54.47

Martin Webber considers a Canadian study about social enterprises and employment opportunities for people with mental health problems such as psychosis.

[read the full story...]

Early intervention in psychosis: how long is long enough?

6999667955_ec45d235b7_k

Rachel Brand looks at a recent RCT which investigates the optimal duration of an early intervention in psychosis programme for young people in Hong Kong.

[read the full story...]

Lifetime prevalence of anxiety disorders in people with bipolar disorder

shutterstock_303720545

Alan Underwood appraises a recent meta-analysis that finds anxiety disorders are three times more common in people with a diagnosis of bipolar disorder.

[read the full story...]

What impact are psychotropic drugs having on our physical health?

shutterstock_227994205

John Baker summarises the findings of a recent review of people with schizophrenia, bipolar disorder and depression. The study looks at the adverse effects on physical health of psychotropic drugs (antipsychotics, antidepressants and mood stabilisers).

[read the full story...]

Can fMRI measuring striatal connectivity help predict response to antipsychotics?

shutterstock_223840864

Samei Huda steps into George Clooney’s shoes to discuss baseline striatal functional connectivity as a predictor of response to antipsychotic drug treatment.

[read the full story...]

Common mental health disorders linked with increased risk of violent reoffending in ex-prisoners

shutterstock_161064980

Ian Cummins considers the implications of a new cohort study of convicted prisoners in Sweden, which links psychiatric disorders with violent reoffending.

[read the full story...]